Results 341 to 348 of about 9,650,018 (348)

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

Annals of Neurology, 1991
R. Terry, E. Masliah, D. Salmon, N. Butters, R. DeTeresa, Robert Hill, L. Hansen, R. Katzman   +7 more
semanticscholar   +1 more source

Alzheimer's disease: the amyloid cascade hypothesis.

Science, 1992
J. Hardy, G. Higgins
semanticscholar   +1 more source

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B

Annals of Neurology, 2004
W. Klunk, H. Engler, A. Nordberg, Yanming Wang, G. Blomqvist, D. Holt, M. Bergström, I. Savitcheva, Guo-feng Huang, S. Estrada, Birgitta Ausén, M. Debnath, J. Barletta, J. Price, J. Sandell, B. Lopresti, A. Wall, P. Koivisto, G. Antoni, C. Mathis, B. Långström   +20 more
semanticscholar   +1 more source

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Nature, 2016
J. Sevigny, P. Chiao, T. Bussiere, P. Weinreb, L. Williams, Marcel Maier, R. Dunstan, S. Salloway, Tianle Chen, Y. Ling, J. O’Gorman, Fang Qian, Mahin F. Arastu, Mingwei Li, Sowmya Chollate, Melanie S. Brennan, Omar Quintero-Monzon, R. Scannevin, H. Arnold, T. Engber, K. Rhodes, Jim Ferrero, Yaming Hang, Alvydas Mikulskis, J. Grimm, C. Hock, R. Nitsch, A. Sandrock   +27 more
semanticscholar   +1 more source

Forecasting the global burden of Alzheimer’s disease

Alzheimer's & Dementia, 2007
R. Brookmeyer, Elizabeth K. Johnson, Kathryn Ziegler-Graham, H. Arrighi   +3 more
semanticscholar   +1 more source

AN ANCIENT APPROACH BUT TURNING INTO FUTURE POTENTIAL SOURCE OF THERAPEUTICS IN ALZHEIMER’S DISEASE

International Research Journal of Pharmacy, 2015
openaire   +1 more source

Neurovascular regulation in the normal brain and in Alzheimer's disease

Nature Reviews Neuroscience, 2004
C. Iadecola
semanticscholar   +1 more source

Hydrophobic Nanocrystals of Donepezil for Sustained Release in Alzheimer’s Disease In Vitro/In Vivo Evaluation

2016
openaire   +1 more source